Month: September 2018
TrialStat Launches Updated TrialStat EDC at SCDM, Introducing New Features to Further Simplify Your Data Management and Study Collaboration Needs – Meet with us at Booth #312 As the volume of per-trial data grows, compliance requirements increase, and Sponsors are more responsible than ever for trial oversight, TrialStat has responded by releasing the next generation…
Read More
“Researchers have now identified three new molecular drug targets in Naegleria fowleri and a number of drugs that are able to inhibit the amoeba’s growth in a laboratory dish. Several of these drugs are already approved by the US Food and Drug Administration for other uses, such as antifungal agents, the breast cancer drug tamoxifen…
Read More
“What happens to skin cells when they are confronted with blood? A team of researchers from Oslo University Hospital, led by Emma Lång and Stig Ove Bøe, performed experiments on blood-deprived cells that were subsequently exposed to blood serum. Remarkably, all the cells started to move and grow in the same direction as soon as…
Read More
“Researchers have discovered how a molecule can help prevent certain types of brain tumors by recognizing and ‘disarming’ harmful proteins that cause them.” Read The Entire Article on the Science Daily Website
Read More